These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 15189493

  • 1. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY, Wilson DM, Buckingham B.
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [Abstract] [Full Text] [Related]

  • 2. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K, Rodriguez LM, Johnson SE, Tadlock S, Heptulla RA.
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [Abstract] [Full Text] [Related]

  • 7. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE.
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 10. Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus.
    Fiallo-Scharer R, Horner B, McFann K, Walravens P, Chase HP.
    J Pediatr; 2006 Apr; 148(4):481-4. PubMed ID: 16647408
    [Abstract] [Full Text] [Related]

  • 11. Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis.
    Lee LJ, Yu AP, Johnson SJ, Birnbaum HG, Atanasov P, Buesching DP, Jackson JA, Davidson JA.
    Diabetes Res Clin Pract; 2010 Jan; 87(1):108-16. PubMed ID: 19896233
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T, Philotheou A, Goldman D, Guo X, Ping L, Cali A, Johnston P.
    Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
    [Abstract] [Full Text] [Related]

  • 16. Insulin glargine: a long-acting insulin for diabetes mellitus.
    Garces K.
    Issues Emerg Health Technol; 2003 Nov; (52):1-4. PubMed ID: 14626260
    [Abstract] [Full Text] [Related]

  • 17. Insulin glargine for type 2 diabetes.
    Hemraj F, Garces K.
    Issues Emerg Health Technol; 2004 Aug; (59):1-4. PubMed ID: 15311441
    [Abstract] [Full Text] [Related]

  • 18. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes].
    Mianowska B, Szadkowska A, Czerniawska E, Pietrzak I, Bodalski J.
    Pediatr Endocrinol Diabetes Metab; 2007 Aug; 13(4):189-93. PubMed ID: 18042313
    [Abstract] [Full Text] [Related]

  • 19. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
    Garg SK, Gottlieb PA, Hisatomi ME, D'Souza A, Walker AJ, Izuora KE, Chase HP.
    Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R, Parton EA, Holzum MK.
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.